ArticleAdvances in therapy2020

A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?

Jie Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.